By: Ann Janssens
Press play button to have the text read to you.
Welcome to the first regular issue of the BJH 2025.
Before going through the content of this issue, the editorial board of the BJH wants to congratulate Prof. Ann De Becker as 13th President of the BHS for the upcoming three years. In her interview we will learn how she, together with the BHS board, wants to meet the BHS mission “Best care for every patient with a haematological problem in Belgium”.
The manuscript “Prime-time for long non-coding RNA (lncRNA) signatures in acute myeloid leukaemia” by Z. Ren et al. (Department of Paediatric Hematology-Oncology and Stem Cell Transplantation, Ghent University Hospital, Ghent) has been selected for REVIEW HEMATOLOGY. The authors describe the strengths and shortcomings of these signatures to personalise treatment strategies.
“Luspatercept in lower-risk myelodysplastic syndromes: Belgian real-life data into perspective” by B. Heyrman et al. (Department of Haematology, ZAS, Antwerp) has been chosen for PHARMACOTHERAPY. The authors confirm the efficacy but also the lack of quality-of-life data to select patients suitable for this treatment better.
HEMATOCASE presents “Severe ADAMTS13 deficit and thrombocytopenia in a case of newly diagnosed systemic lupus erythematosus with antiphospholipid syndrome” by L. Dassy et al. (Department of Haematology, CHU Liège, Liège). The rapid initiation of treatment probably prevented the occurrence of thrombotic microangiopathy and provided a favourable serological and clinical evolution of the lupus with APL syndrome of this patient.
“The complementary value of human and canine mast cell neoplasia” from S. De Vos et al. (Faculty of Veterinary Medicine, Ghent University, Merelbeke) is the subject of HEMATOTHESIS. Since mast cell tumours are common in dogs, they could provide a translational model studying this tumour type in humans.
The issue concludes with the oral and poster presentations selected from the annual meeting of the Belgian Society on Thrombosis and Haemostasis (BSTH), which took place on 27–28 November 2024, in Mechelen.
Enjoy reading,
Ann Janssens, MD, PhD
Editor-in-Chief
Top
